Skip to main content

Table 2 Studies with data on barriers to and/or enablers of ART uptake in the context of integrated HIV/TB treatment in sub-Saharan Africa

From: Barriers to and enablers of uptake of antiretroviral therapy in integrated HIV and tuberculosis treatment programmes in sub-Saharan Africa: a systematic review and meta-analysis

Author, year Setting Research method/
Study design
Participants Sample size
Kumwenda, 2011 Rural and urban Malawi Mixed methods: historical cohort study (quantitative) and cross-sectional survey with IDIs (qualitative) 996 HIV/TB co-infected patients
99 newly registered TB patients for IDIs
996-quantitative
99-qualitative
Patel, 2014 Urban DRC Quantitative: Prospective cohort HIV/TB co-infected patients 492
Pepper, 2011 Urban slum,
South Africa
Quantitative: Secondary analysis of prospective cohort data HIV/TB co-infected patients 100
Levin, 2006 Urban South Africa Mixed-methods cross-sectional study using semi-structured questionnaire with qualitative fields HIV/TB co-infected persons of predominantly low socioeconomic status 85
Nansera, 2010 Rural Uganda Mixed methods: cross-sectional study including key informant interviews for qualitative data Workers of 22 health units 88
Njozing, 2010 Rural and urban Cameroon Quantitative: retrospective cohort Staff of hospitals providing TB/HIV treatment and support services 1220
Ndagijimana, 2015 Rural and urban Rwanda Mixed methods:
Quantitative component: Retrospective cohort
Qualitative component: cross-sectional with data collection via IDIs and FGDs
-Staff of health facilities (IDIs)
-HIV/TB co-infected patients (FGDs)
24 IDIs and 12 FGDs
Wajanga, 2014 Urban Tanzania Qualitative: Cross-sectional with data collection via IDIs Hospital staff including administrators, laboratory technicians, pharmacists, and physicians 26 IDIs
Chileshe, 2010 Rural Zambia Qualitative: ethnographic case-studies HIV/TB co-infected patients and their households 7 case studies
Tweya, 2014 Urban Malawi Quantitative: retrospective cohort HIV/TB co-infected patients 377
  1. IDI In-depth interview, FGD focus-group discussion, DRC democratic Republic of Congo